Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Semin Immunol ; 26(5): 357-68, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24486056
2.
J Immunol ; 191(11): 5383-97, 2013 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-24140643

RESUMEN

Soluble CD23 plays a role in the positive regulation of an IgE response. Engagement of the ß2 adrenergic receptor (ß2AR) on a B cell is known to enhance the level of both soluble CD23 and IgE, although the mechanism by which this occurs is not completely understood. In this study, we report that, in comparison with a CD40 ligand/IL-4-primed murine B cell alone, ß2AR engagement on a primed B cell increased gene expression of a disintegrin and metalloproteinase (ADAM)10, which is the primary sheddase of CD23, as well as protein expression of both CD23 and ADAM10, in a protein kinase A- and p38 MAPK-dependent manner, and promoted the localization of these proteins to exosomes as early as 2 d after priming, as determined by both Western blot and flow cytometry and confirmed by electron microscopy. In comparison with isolated exosomes released from primed B cells alone, the transfer of exosomes released from ß2AR agonist-exposed primed B cells to cultures of recipient primed B cells resulted in an increase in the level of IgE produced per cell, without affecting the number of cells producing IgE, as determined by ELISPOT. These effects still occurred when a ß2AR antagonist was added along with the transfer to block residual agonist, and they failed to occur when exosomes were isolated from ß2AR-deficient B cells. These findings suggest that the mechanism responsible for mediating the ß2AR-induced increase in IgE involves a shuttling of the ß2AR-induced increase in CD23 and ADAM10 proteins to exosomes that subsequently mediate an increase in IgE.


Asunto(s)
Proteínas ADAM/metabolismo , Secretasas de la Proteína Precursora del Amiloide/metabolismo , Linfocitos B/inmunología , Exosomas/metabolismo , Inmunoglobulina E/metabolismo , Proteínas de la Membrana/metabolismo , Receptores de IgE/metabolismo , Proteínas ADAM/genética , Proteína ADAM10 , Agonistas de Receptores Adrenérgicos beta 2/farmacología , Secretasas de la Proteína Precursora del Amiloide/genética , Animales , Linfocitos B/efectos de los fármacos , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/inmunología , Inmunoglobulina E/genética , Inmunoglobulina E/inmunología , Activación de Linfocitos/efectos de los fármacos , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , Transporte de Proteínas , Receptores Adrenérgicos beta 2/genética , Receptores Adrenérgicos beta 2/inmunología , Receptores de IgE/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
3.
J Neurophysiol ; 105(6): 2772-80, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21430270

RESUMEN

The voltage-gated K(+) channel Kv1.3 has been reported to regulate transmitter release in select central and peripheral neurons. In this study, we evaluated its role at the synapse between visceral sensory afferents and secondary neurons in the nucleus of the solitary tract (NTS). We identified mRNA and protein for Kv1.3 in rat nodose ganglia using RT-PCR and Western blot analysis. In immunohistochemical experiments, anti-Kv1.3 immunoreactivity was very strong in internal organelles in the soma of nodose neurons with a weaker distribution near the plasma membrane. Anti-Kv1.3 was also identified in the axonal branches that project centrally, including their presynaptic terminals in the medial and commissural NTS. In current-clamp experiments, margatoxin (MgTx), a high-affinity blocker of Kv1.3, produced an increase in action potential duration in C-type but not A- or Ah-type neurons. To evaluate the role of Kv1.3 at the presynaptic terminal, we examined the effect of MgTx on tract evoked monosynaptic excitatory postsynaptic currents (EPSCs) in brain slices of the NTS. MgTx increased the amplitude of evoked EPSCs in a subset of neurons, with the major increase occurring during the first stimuli in a 20-Hz train. These data, together with the results from somal recordings, support the hypothesis that Kv1.3 regulates the duration of the action potential in the presynaptic terminal of C fibers, limiting transmitter release to the postsynaptic cell.


Asunto(s)
Potenciales Postsinápticos Excitadores/genética , Canal de Potasio Kv1.3/metabolismo , Neuronas/fisiología , Núcleo Solitario/citología , Núcleo Solitario/metabolismo , Análisis de Varianza , Animales , Animales Recién Nacidos , Cuerpos Aórticos/metabolismo , Biofisica/métodos , Estimulación Eléctrica , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Técnicas In Vitro , Canal de Potasio Kv1.3/genética , Masculino , Fibras Nerviosas Amielínicas/fisiología , Neuronas/efectos de los fármacos , Técnicas de Placa-Clamp/métodos , Bloqueadores de los Canales de Potasio/farmacología , Terminales Presinápticos/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Venenos de Escorpión/farmacología , Bloqueadores de los Canales de Sodio/farmacología , Núcleo Solitario/efectos de los fármacos , Transmisión Sináptica/efectos de los fármacos , Tetrodotoxina/farmacología , Proteína 2 de Transporte Vesicular de Glutamato/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA